VIRAL SUPPRESSION AT WEEK 4 EXCEEDS THE IL28B SNP FOR PREDICTING SVR IN PEGYLATED INTERFERON PLUS RIBAVIRIN COMBINATION THERAPY OF GENOTYPE 1 INFECTED PATIENTS WITH CHRONIC HEPATITIS C

被引：0
|
作者：
Oze, Tsugiko [1 ]
Hiramatsu, Naoki [1 ]
Yakushijin, Takayuki [1 ]
Doi, Yoshinori [2 ]
Ogawa, Hiroyuki [3 ]
Hagiwara, Hideki [4 ]
Mita, Eiji [5 ]
Kaneko, Akira [6 ]
Katayama, Kazuhiro [7 ]
Hijioka, Taizo [8 ]
Tamura, Shinji [9 ]
Yoshihara, Harumasa [10 ]
Inoue, Atsuo [11 ]
Imai, Yasuharu [12 ]
Hayashi, Eijirou [13 ]
Hosui, Atsushi [1 ]
Miyagi, Takuya [1 ]
Yoshida, Yuichi [1 ]
Tatsumi, Tomohide [1 ]
Kiso, Shinichi [1 ]
Kanto, Tatsuya [1 ]
Kasahara, Akinori [1 ]
Hayashi, Norio [4 ]
Takehara, Tetsuo [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan
[2] Otemae Hosp, Osaka, Japan
[3] Nishinomiya Municipal Cent Hosp, Nishinomiya, Hyogo, Japan
[4] Kansai Rousai Hosp, Amagasaki, Hyogo, Japan
[5] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan
[6] NTT W Osaka Hosp, Osaka, Japan
[7] Natl Hosp Org Osaka Minami Med Ctr, Kawachi Nagano, Japan
[8] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan
[9] Minoh City Hosp, Mino, Japan
[10] Osaka Rosai Hosp, Sakai, Osaka, Japan
[11] Osaka Gen Med Ctr, Osaka, Japan
[12] Ikeda Municipal Hosp, Ikeda, Osaka, Japan
[13] Mutual Aid Assoc Publ Sch Teacher, Kinki Cent Hosp, Itami, Hyogo, Japan
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：852A / 853A
页数：2
相关论文
共 50 条
  • [21] Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
    Yasuhito Tanaka
    Nao Nishida
    Masaya Sugiyama
    Masayuki Kurosaki
    Kentaro Matsuura
    Naoya Sakamoto
    Mina Nakagawa
    Masaaki Korenaga
    Keisuke Hino
    Shuhei Hige
    Yoshito Ito
    Eiji Mita
    Eiji Tanaka
    Satoshi Mochida
    Yoshikazu Murawaki
    Masao Honda
    Akito Sakai
    Yoichi Hiasa
    Shuhei Nishiguchi
    Asako Koike
    Isao Sakaida
    Masatoshi Imamura
    Kiyoaki Ito
    Koji Yano
    Naohiko Masaki
    Fuminaka Sugauchi
    Namiki Izumi
    Katsushi Tokunaga
    Masashi Mizokami
    Nature Genetics, 2009, 41 : 1105 - 1109
  • [22] Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotype 1b and high viral load
    Soo Ryang Kim
    Ahmed El-Shamy
    Susumu Imoto
    Ke Ih Kim
    Yoshi-hiro Ide
    Lin Deng
    Ikuo Shoji
    Yasuhito Tanaka
    Yutaka Hasegawa
    Mitsuhiro Ota
    Hak Hotta
    Journal of Gastroenterology, 2012, 47 : 1143 - 1151
  • [23] Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotype 1b and high viral load
    Kim, Soo Ryang
    El-Shamy, Ahmed
    Imoto, Susumu
    Kim, Ke Ih
    Ide, Yoshi-hiro
    Deng, Lin
    Shoji, Ikuo
    Tanaka, Yasuhito
    Hasegawa, Yutaka
    Ota, Mitsuhiro
    Hotta, Hak
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (10) : 1143 - 1151
  • [24] Association of Interleukin-28B and Hepatitis C Genotype 1 with a High Viral Load and Response to Pegylated Interferon plus Ribavirin Therapy
    Takita, Masahiro
    Hagiwara, Satoru
    Arizumi, Tadaaki
    Hayaishi, Sousuke
    Ueda, Taisuke
    Kitai, Satoshi
    Yada, Norihisa
    Inoue, Tatsuo
    Minami, Yasunori
    Chung, Hobyung
    Ueshima, Kazuomi
    Sakurai, Toshiharu
    Kudo, Masatoshi
    DIGESTION, 2011, 84 : 56 - 61
  • [25] IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α
    Holmes, Jacinta A.
    Tin Nguyen
    Ratnam, Dilip
    Heerasing, Neel M.
    Tehan, Jane V.
    Bonanzinga, Sara
    Dev, Anouk
    Bell, Sally
    Pianko, Stephen
    Chen, Robert
    Visvanathan, Kumar
    Hammond, Rachel
    Iser, David
    Rusli, Ferry
    Sievert, William
    Desmond, Paul V.
    Bowden, D. Scott
    Thompson, Alexander J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (05) : 861 - 866
  • [26] A single nucleotide polymorphism in IL28B affects viral evolution of hepatitis C quasispecies after pegylated interferon and ribavirin therapy
    Yuan, Hejun
    Adams-Huet, Beverley
    Petersen, Tianna
    Attar, Nahid
    Lee, William M.
    Jain, Mamta K.
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (12) : 1913 - 1919
  • [27] Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype
    Itokawa, Norio
    Atsukawa, Masanori
    Tsubota, Akihito
    Kondo, Chisa
    Hashimoto, Satomi
    Fukuda, Takeshi
    Matsushita, Yoko
    Kidokoro, Hideko
    Kobayashi, Tamaki
    Narahara, Yoshiyuki
    Nakatsuka, Katsuhisa
    Kanazawa, Hidenori
    Iwakiri, Katsuhiko
    Sakamoto, Choitsu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (03) : 443 - 449
  • [28] Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4
    Martin-Carbonero, L.
    Puoti, M.
    Garcia-Samaniego, J.
    De Luca, A.
    Losada, E.
    Quinzan, G.
    Bruno, R.
    Marino, A.
    Gonzalez, M.
    Nunez, M.
    Soriano, V.
    JOURNAL OF VIRAL HEPATITIS, 2008, 15 (10) : 710 - 715
  • [29] ADDITIONAL USE OF PITAVASTATIN WITH PEGYLATED INTERFERON PLUS RIBAVIRIN THERAPY ENHANCES VIRAL SUPPRESSION IN PATIENTS WITH CHRONIC HEPATITIS C
    Shimada, Masahiko
    Yoshida, Shuhei
    Kornek, Miroslaw
    Takegoshi, So
    Tadokoro, Hiroyuki
    Yoshino, Morihiko
    HEPATOLOGY, 2010, 52 (04) : 755A - 755A
  • [30] Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1
    Ogawa, Eiichi
    Furusyo, Norihiro
    Murata, Masayuki
    Ikezaki, Hiroaki
    Ihara, Takeshi
    Hayashi, Takeo
    Toyoda, Kazuhiro
    Taniai, Hiroaki
    Okada, Kyoko
    Kainuma, Mosaburo
    Hayashi, Jun
    JOURNAL OF HEPATOLOGY, 2012, 57 (03) : 534 - 540
12345